Sort
17,288 grants matching “multiple sclerosis”
Lipidomic profile of endocannabinoids from neuronal cells
$190,625Eric L Barker · Purdue University · R21 · FY2010 · DA
MicroRNA Modulation of Immune Function in Multiple Sclerosis
$190,625Caroline C Whitacre · Ohio State University · R21 · FY2012 · AI
The role of Kainate receptors in oligodendrocyte toxicity and EAE
$190,625Geoffrey T Swanson · Northwestern University At Chicago · R21 · FY2009 · NS
Discovery and evaluation of novel therapy for Niemann-Pick type C targeting NPC1
$190,625Sarah Spiegel · Virginia Commonwealth University · R21 · FY2015 · NS
An Immune Tolerance Strategy for Prevention and Treatment of Atherosclerosis
$190,625Jayme Borensztajn · Northwestern University At Chicago · R21 · FY2011 · HL
Small molecule effectors of maternal gene expression in C. elegans embryogenesis
$190,625Sean Patrick Ryder · Univ Of Massachusetts Med Sch Worcester · R21 · FY2007 · NS
CaMKIIbeta: a regulator of CNS myelination
$190,625Babette Fuss · Virginia Commonwealth University · R21 · FY2014 · NS
Encapsulated Active Vitamin D Vaccine for the Treatment of Multiple Sclerosis
$190,625Kristy M Ainslie · Ohio State University · R21 · FY2012 · NS
The protective effect of Emmprin inhibition in acute cerebrovascular disease.
$190,575Louise Deborah McCullough · University Of Connecticut Sch Of Med/Dnt · R21 · FY2014 · NS
Transcriptome analysis of glia responding to injury
$190,575Mary Allison Logan · Oregon Health & Science University · R21 · FY2014 · NS
Role of ERK1/ERK2 MAP Kinase in Myelin Assembly and Maintenance
$190,575Rashmi Bansal · University Of Connecticut Sch Of Med/Dnt · R21 · FY2014 · NS
Just-In-Time Fall Prevention: Development of an mHealth Intervention for Persons with Multiple Sclerosis
$190,538Ryan S. McGinnis · University Of Vermont & St Agric College · R21 · FY2019 · EB
Mechanism of MALT1 Regulation by a Novel Ubiquitin Ligase
$190,534Hongmin Li · Wadsworth Center · R21 · FY2016 · AI
TDP43 Degradation by the Lysosomal Proteases in Amyotrophic Lateral Sclerosis
$190,512Paul Joseph Sampognaro · University Of California, San Francisco · K08 · FY2022 · NS
Type I Interferon signaling in Bordetella pertussis pathogenesis
$190,400Nicholas H. Carbonetti · University Of Maryland Baltimore · R21 · FY2019 · AI
Drug Transport Mechanisms at the Blood-CSF Barrier and Effect of Aging
$190,309Joanne Wang · University Of Washington · R21 · FY2022 · AG
Clinical subjects and recruitment
$190,271Albert C Shaw · Yale University · U19 · FY2025 · AI
Just-In-Time Fall Prevention: Development of an mHealth Intervention for Persons with Multiple Sclerosis
$190,266Ryan S. McGinnis · University Of Vermont & St Agric College · R21 · FY2021 · EB
Fibroblast TGF-beta/Smad Signaling in Scleroderma
$190,216University Of Illinois At Chicago · R01 · FY2004 · AR
PDGF-A AND FGF2: IN VIVO ROLES DURING CNS REMYELINATION
$190,196Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2003 · NS
Dissemination of the Clinical Practice Guideline entitled Complementary and
$190,157Pushpa Narayanaswami · American Academy Of Neurology · R18 · FY2013 · HS
Investigating Correlates and Therapeutics of Fatigue
$190,152Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2019 · NR
EAGER: Unraveling the mechanism and the role of anti- inflammatory nanoparticles in multiple sclerosis model
$190,134Sudipta Seal · The University Of Central Florida Board Of Trustees · · FY2013 · ENG
EFFECTOR MOLECULES IN DEMYELINATING DISEASE
$190,102Washington University · R01 · FY2001 · NS
MRI paramagnetic rim lesions as biomarkers and agents of neurodegeneration in multiple sclerosis
$190,058Christopher C. Hemond · Univ Of Massachusetts Med Sch Worcester · K23 · FY2022 · NS